SCHEMBL24079182

SCHEMBL24079182

CCCCc1cc2cc(O)cc(O)c2c(O)c1C(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
MAPK1 P28482 1/20 0.46
PTPN1 P18031 3/20 0.43
PTPN11 Q06124 2/20 0.43
TYR P14679 2/20 0.43
CYP3A4 P08684 2/20 0.42
HPGD P15428 1/20 0.42
PTGES O14684 2/20 0.41
TOP2A P11388 1/20 0.41
PRKCI P41743 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 2/20 0.38
HTT P42858 2/20 0.38
TP53 P04637 1/20 0.38
ALOX5 P09917 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15782864 0.87 MEN1 (0.48) MEN1KMT2AKDM4EPTPN1PTPN11
SCHEMBL24079188 0.82 PRKCI (0.46) MEN1KMT2AALDH1A1KDM4EPRKCI
SCHEMBL19840682 0.81 PTPN1 (0.60) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL12800168 0.74 CYP3A4 (0.52) MEN1KMT2AALDH1A1MAPK1CYP3A4
SCHEMBL19841049 0.74 PRKCI (0.42) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL19841038 0.74 CHEK1 (0.43) PRKCI
SCHEMBL588920 0.73 PRKCI (0.44) PRKCIMAPTHTTESR1ESR2
SCHEMBL29406040 0.73 ANTXR2 (0.39) MEN1KMT2AALDH1A1KDM4EGAA
SCHEMBL29358360 0.72 NR4A1 (0.53) MEN1KMT2AALDH1A1PTGESPOLB
SCHEMBL21569598 0.71 PRKCI (0.39) TYRPRKCIPPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192866-B2 Synthesis of tetracyclines and analogues thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2021-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192866-B2 Synthesis of tetracyclines and analogues thereof TET1, TET3, MYC MEN1 1643/4885KMT2A 535/4885ALDH1A1 4455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.